Abiopharma

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty Corporation - XOMA

HALEON PLC (HLN) Files Form 6-K

New Form 25-NSE - QIAGEN N.V. Filed: 2026-01-08 AccNo: 0000876661-26-000016 Size: 4 KB

📋 Hui Yvonne (Officer) plans to sell 372 shares of Phreesia, Inc. (at $17.47 each, total $6K) Filed: Jan 08, 2026 | ID: 000202

New Form SCHEDULE 13G/A - 10x Genomics, Inc. Filed: 2026-01-08 AccNo: 0000315066-26-000056 Size: 14 KB

New Form SCHEDULE 13G/A - VERACYTE, INC. Filed: 2026-01-08 AccNo: 0001104659-26-001972 Size: 13 KB

New Form SC TO-I/A - Anebulo Pharmaceuticals, Inc. Filed: 2026-01-08 AccNo: 0001493152-26-000914 Size: 55 KB

📋 Sofinnova Crossover I SLP (Affiliate) plans to sell 1.0M shares of Abivax S.A. (at $133.70 each, total $133.7M) Filed: Jan 08, 2026 | ID: 001973

CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC AI INSIGHTS INITIATIVE TO OPTIMIZE TRADITIONAL CHINESE MEDICINE PORTFOLIO, ENHANCE MARKET ANALYSIS AND EXPLORE AI-SUPPORTED CLINIC DEPLOYMENT

VolitionRx Secures $2.0 Million in Funding

Akari Therapeutics to Present at the 2026 Biotech Showcase

Genelux Corporation Announces Pricing of $20.0 Million Underwritten Public Offering of Common Stock

(10% Negative) TANGO THERAPEUTICS, INC. (TNGX) Announces Clinical Trial Timeline Adjustment